Stuvia.com - The Marketplace to Buy and Sell your Study Material
OLIVIA JONES VSIM
OLIVIA JONES-Vsim.
Name of Drug: Oxytocin
Pharmacologic Class: exogenous hormones
Therapuetic Class: oxytocics, lactation stimulant
Therapeutic Level:
Indication for Use:
IV: Induction of labor at term. IV: Facilitation of threatened abortion. IV, IM: Postpartum
control of bleeding after expulsion of the placenta.
The nursing interventions associated with each drug are:
Assessed fetal maturity, presentation, and pelvic adequacy prior to administration of oxytocin for
induction of labor.
Assess character, frequency, and duration of uterine contractions; resting uterine tone; and fetal
heart rate regularly throughout administration. If contractions occur 2 min apart and are 50– 65
mm Hg on monitor, if they last 60– 90 sec or longer, or if a significant change in fetal heart rate
develops, stop infusion and turn patient on her left side to prevent fetal anoxia. Notify health care
professional immediately.
Monitor maternal BP and pulse frequently and fetal heart rate continuously throughout
administration.
Monitor patient for signs and symptoms of drowsiness, listlessness, confusion, headache, anuria,
and notify physician or other health care professional if they occur.
Monitor maternal electrolytes due to water retention that may result in hypochloremia or
hyponatremia.
Name of Drug: Magnesium Sulfate
Therapeutic Class: Electrolyte replacements /supplements and mineral
Pharmacologic Class: Minerals/electrolytes
Therapeutic Level: 3.5 to 7 mEq/L, or 4.2 to 8.4 mg/dL.
Indication for Use:
Treatment of hypo magnesium and hypertension; prevention of seizures r/t eclampsia and pre-
eclampsia
Downloaded by: dennys |
Distribution of this document is illegal
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
The nursing interventions associated with each drug are:
Monitor pulse, BP, respirations, and ECG frequently throughout administration of parenteral
magnesium sulfate. Respirations should be at least 16/min before each dose.
Monitor neurologic status before and throughout therapy. Initiate seizure precautions. Patellar
reflex /knee jerk should be assessed before each parenteral dose of magnesium sulfate. If
response is absent, no additional doses should be administered until positive response is
obtained.
Monitor newborn for hypotension, hyporeflexia, and respiratory depression if mother has
received magnesium sulfate.
Monitor intake and output ratios. Urine output should be maintained at a level of at least 100
mL/4 hr.
Monitor serum magnesium levels and renal function regularly during administration of
parenteral magnesium sulfate.
PATIENT TEACHINGS
Name of Drug: Oxytocin
Patient Education:
Advise patient to expect contractions like menstrual cramps after administration has started.
Educate patient to immediately report adverse reactions, such as site irritation, nausea, bleeding,
blurred vision, difficulty speaking, wheezing, itching, and swelling.
Educate patient and family about the administration and use of the drug.
Potential Nursing Diagnoses for each drug:
Deficient knowledge, related to medication regimen (Patient/Family Teaching)
Name of Drug: Magnesium Sulfate
Patient Education:
Explain purpose of medication to patient and family.
Explain use and administration of drug to patient and family.
Emphasize importance of keeping lab appointments.
Educate patient about warning signs of high or low magnesium level and to report all adverse
effects/reactions.
Downloaded by: dennys |
Distribution of this document is illegal
OLIVIA JONES VSIM
OLIVIA JONES-Vsim.
Name of Drug: Oxytocin
Pharmacologic Class: exogenous hormones
Therapuetic Class: oxytocics, lactation stimulant
Therapeutic Level:
Indication for Use:
IV: Induction of labor at term. IV: Facilitation of threatened abortion. IV, IM: Postpartum
control of bleeding after expulsion of the placenta.
The nursing interventions associated with each drug are:
Assessed fetal maturity, presentation, and pelvic adequacy prior to administration of oxytocin for
induction of labor.
Assess character, frequency, and duration of uterine contractions; resting uterine tone; and fetal
heart rate regularly throughout administration. If contractions occur 2 min apart and are 50– 65
mm Hg on monitor, if they last 60– 90 sec or longer, or if a significant change in fetal heart rate
develops, stop infusion and turn patient on her left side to prevent fetal anoxia. Notify health care
professional immediately.
Monitor maternal BP and pulse frequently and fetal heart rate continuously throughout
administration.
Monitor patient for signs and symptoms of drowsiness, listlessness, confusion, headache, anuria,
and notify physician or other health care professional if they occur.
Monitor maternal electrolytes due to water retention that may result in hypochloremia or
hyponatremia.
Name of Drug: Magnesium Sulfate
Therapeutic Class: Electrolyte replacements /supplements and mineral
Pharmacologic Class: Minerals/electrolytes
Therapeutic Level: 3.5 to 7 mEq/L, or 4.2 to 8.4 mg/dL.
Indication for Use:
Treatment of hypo magnesium and hypertension; prevention of seizures r/t eclampsia and pre-
eclampsia
Downloaded by: dennys |
Distribution of this document is illegal
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
The nursing interventions associated with each drug are:
Monitor pulse, BP, respirations, and ECG frequently throughout administration of parenteral
magnesium sulfate. Respirations should be at least 16/min before each dose.
Monitor neurologic status before and throughout therapy. Initiate seizure precautions. Patellar
reflex /knee jerk should be assessed before each parenteral dose of magnesium sulfate. If
response is absent, no additional doses should be administered until positive response is
obtained.
Monitor newborn for hypotension, hyporeflexia, and respiratory depression if mother has
received magnesium sulfate.
Monitor intake and output ratios. Urine output should be maintained at a level of at least 100
mL/4 hr.
Monitor serum magnesium levels and renal function regularly during administration of
parenteral magnesium sulfate.
PATIENT TEACHINGS
Name of Drug: Oxytocin
Patient Education:
Advise patient to expect contractions like menstrual cramps after administration has started.
Educate patient to immediately report adverse reactions, such as site irritation, nausea, bleeding,
blurred vision, difficulty speaking, wheezing, itching, and swelling.
Educate patient and family about the administration and use of the drug.
Potential Nursing Diagnoses for each drug:
Deficient knowledge, related to medication regimen (Patient/Family Teaching)
Name of Drug: Magnesium Sulfate
Patient Education:
Explain purpose of medication to patient and family.
Explain use and administration of drug to patient and family.
Emphasize importance of keeping lab appointments.
Educate patient about warning signs of high or low magnesium level and to report all adverse
effects/reactions.
Downloaded by: dennys |
Distribution of this document is illegal
